Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant-Reference-Cited by-同舟云学术

Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant

Published:2012-02-19 Issue:5 Volume:20 Page:891-892
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Tendas Andrea,Sollazzo Fabio,Bruno Antonio,Cupelli Luca,Niscola Pasquale,Pignatelli Adriana Concetta,Dentamaro Teresa,de Fabritiis Paolo,Arcese William

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-012-1411-1.pdf

Reference4 articles.

1. Einhorn LH, Grunberg SM, Rapoport B, Rittenberg C, Feyer P (2011) Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement. Support Care Canc 19(Suppl 1):S1–S4

2. Kris MG et al (2011) Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Support Care Canc 19(Suppl 1):S25–S32

3. Alessandrino P et al (1999) Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 23(6):533–537

4. Tendas A et al (2010) Epidemiology of pain in haemopoietic stem cell transplantation: result of a day-by-day pain assessment tool. Bone Marrow Transplant 45(Suppl 2):S1–S427, Abstracts of EBMT (European Group for Blood and Bone Marrow Transplantation) 2010. March 21–14, 2010, Wien (Oesterreich)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation;Clinical Hematology International;2022-07-11

2. Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation;Supportive Care in Cancer;2021-09-17

3. Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience;Supportive Care in Cancer;2021-08-04

4. Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions;Supportive Care in Cancer;2018-12-18

5. Chemotherapy-induced Nausea and Vomiting Prophylaxis in High-dose Melphalan and Autologous Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2018-02